Stonepine Capital Management, LLC Spero Therapeutics, Inc. Transaction History
Stonepine Capital Management, LLC
- $102 Billion
- Q2 2025
A detailed history of Stonepine Capital Management, LLC transactions in Spero Therapeutics, Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 156,888 shares of SPRO stock, worth $370,255. This represents 0.45% of its overall portfolio holdings.
Number of Shares
156,888Holding current value
$370,255% of portfolio
0.45%Shares
3 transactions
Others Institutions Holding SPRO
# of Institutions
48Shares Held
10.4MCall Options Held
0Put Options Held
186K-
Vanguard Group Inc Valley Forge, PA1.95MShares$4.6 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.62MShares$3.81 Million0.86% of portfolio
-
Atlas Venture Associates Ix, LLC Boston, MA1.35MShares$3.19 Million14.54% of portfolio
-
Alphabet Inc. Mountain View, CA890KShares$2.1 Million0.17% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny832KShares$1.96 Million0.0% of portfolio
About Spero Therapeutics, Inc.
- Ticker SPRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,067,500
- Market Cap $82.8M
- Description
- Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...